Microferk 2 gram-positive bacteria drug Minka antibiotics-macrocyclics, lincomamides, streptomericins, endolipids
Taiwan·Risk Class 2·BIOMERIEUX, INC.·Registered Apr 19, 2013 – Apr 19, 2028Active- Analysis ID
- d961d77c8f92cd4b4a9a38c5636b2c59
- Customs Code
- DHA00602458405
- Manufacturer
- BIOMERIEUX, INC.
- Manufacturer Country
- United States
- Authorized Representative
- Hong Kong Commercial Mérieux S.p.A. Taiwan Branch
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.1645 Automatic Antibiotic Sensitivity Test System for Short Incubation Period
- Import Information
- import
- Registration Date
- Apr 19, 2013
- Expiry Date
- Apr 19, 2028
Access comprehensive regulatory information for Microferk 2 gram-positive bacteria drug Minka antibiotics-macrocyclics, lincomamides, streptomericins, endolipids in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d961d77c8f92cd4b4a9a38c5636b2c59 and manufactured by BIOMERIEUX, INC.. The authorized representative in Taiwan is Hong Kong Commercial Mérieux S.p.A. Taiwan Branch.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.